Silverfin false false 30/04/2026 30/04/2026 01/05/2025 no description of principal activity Dr S Zenalabdin 11/04/2014 08993417 2026-04-30 08993417 bus:Director1 2026-04-30 08993417 2025-04-30 08993417 core:CurrentFinancialInstruments 2026-04-30 08993417 core:CurrentFinancialInstruments 2025-04-30 08993417 2025-05-01 2026-04-30 08993417 bus:Micro-entities 2025-05-01 2026-04-30 08993417 bus:FilletedAccounts 2025-05-01 2026-04-30 08993417 bus:AuditExemptWithAccountantsReport 2025-05-01 2026-04-30 08993417 bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 08993417 bus:Director1 2025-05-01 2026-04-30 08993417 2024-05-01 2025-04-30 iso4217:GBP xbrli:pure

Company No: 08993417 (England and Wales)

# SAAB MEDICAL LIMITED

### Unaudited Financial Statements
For the financial year ended 30 April 2026
Pages for filing with the registrar

SAAB MEDICAL LIMITED

## UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 30 April 2026

Contents

SAAB MEDICAL LIMITED

## BALANCE SHEET

As at 30 April 2026
SAAB MEDICAL LIMITED

## BALANCE SHEET (continued)

For the financial year ended 30 April 2026

|  | 2026 |  | 2025
|  | £ |  | £
Fixed assets |  | - |  | 322
Current assets |  | 8,454 |  | 8,517
Creditors: amounts falling due within one year |  | ( 2,839) |  | ( 2,247)
Net current assets |  | 5,615 |  | 6,270
Total assets less current liabilities |  | 5,615 |  | 6,592
Net assets |  | 5,615 |  | 6,592
Capital and reserves |  | 5,615 |  | 6,592

For the financial year ending 30 April 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
- These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
- These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Saab Medical Limited (registered number: 08993417) were approved and authorised for issue by the director on 27 July 2026 and were signed on its behalf by:

Dr S Zenalabdin Director |

SAAB MEDICAL LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2026
SAAB MEDICAL LIMITED

## NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 30 April 2026

#### 1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 08993417). The address of its registered office is 21 Godmond Hall Drive, Worsley, Manchester, M28 1YF, United Kingdom.

#### 2. Employees

| 2026 |  | 2025
| Number |  | Number
Monthly average number of persons employed by the Company during the financial year, including the director | 1 |  | 1